EXAS
USDExact Sciences Corporation Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$70.070
Максимум
$72.810
Минимум
$67.970
Объем
1.54M
Фундаментальные показатели компании
Рыночная капитализация
13.2B
Отрасль
Diagnostics & Research
Страна
United States
Статистические данные торговли
Средний объем
2.95M
Биржа
NCM
Валюта
USD
52-недельный диапазон
Связанные новости
TD Cowen Maintains Buy on Exact Sciences, Raises Price Target to $90
TD Cowen analyst Dan Brennan maintains Exact Sciences with a Buy and raises the price target from $74 to $90.
Baird Maintains Outperform on Exact Sciences, Raises Price Target to $88
Baird analyst Catherine Schulte maintains Exact Sciences with a Outperform and raises the price target from $72 to $88.
Benchmark Maintains Buy on Exact Sciences, Raises Price Target to $75
Benchmark analyst Bruce D. Jackson maintains Exact Sciences with a Buy and raises the price target from $60 to $75.
Guggenheim Maintains Buy on Exact Sciences, Raises Price Target to $75
Guggenheim analyst Subbu Nambi maintains Exact Sciences with a Buy and raises the price target from $70 to $75.
Barclays Maintains Overweight on Exact Sciences, Raises Price Target to $77
Barclays analyst Luke Sergott maintains Exact Sciences with a Overweight and raises the price target from $65 to $77.
Stifel Maintains Buy on Exact Sciences, Raises Price Target to $80
Stifel analyst Daniel Arias maintains Exact Sciences with a Buy and raises the price target from $67 to $80.
Exact Sciences to Participate in November Investor Conference
Exact Sciences Corp. (NASDAQ:EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate
Связанные акции
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.